Strategies to identify sequences or antigens unique to multiple sclerosis

Area of Science:

• Neuroimmunology
• Molecular Biology
• Central Nervous System (CNS) Diseases

Background:

• Chronic CNS diseases like multiple sclerosis (MS) show elevated IgG and oligoclonal bands (OGBs) in cerebrospinal fluid (CSF).
• In known CNS infections, OGBs target the pathogen; in MS, their antigenic specificity remains unclear, possibly involving infectious agents or autoantigens.
• Identifying MS-specific antigens is crucial for understanding disease pathogenesis.

Purpose of the Study:

• To identify antigens specific to multiple sclerosis (MS) using a molecular approach.
• To analyze the IgG repertoire within MS brain plaques to find disease-relevant sequences.
• To develop tools for identifying unique MS antigens.

Main Methods:

• Construction of directional cDNA expression libraries from MS brain tissue (plaques and periplaque white matter).
• Screening libraries for clones reacting with MS CSF but not with CSF from other CNS diseases.
• Subtraction hybridization with normal brain mRNA to identify unique MS transcripts.
• Polymerase chain reaction (PCR) amplification, cloning, and sequencing of IgG heavy (VH) and light (VL) chain variable regions from MS plaques.

Main Results:

• Analysis of the IgG VH and VL repertoire in MS brain tissue was performed.
• Identification of disease-relevant IgG sequences is anticipated.
• Recombinant antibodies will be generated from these sequences.

Conclusions:

• The study provides a molecular strategy to identify MS-specific antigens.
• Analysis of the IgG repertoire in MS plaques can reveal disease-relevant sequences.
• Recombinant antibodies derived from these sequences will aid in identifying antigens unique to MS, advancing understanding of its pathogenesis.